Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
MicroRNAs01:22

MicroRNAs

4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1<sup>+</sup> progenitor CD8<sup>+</sup> T cells to improve immunotherapy.

Nature immunology·2024
Same author

Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockade.

Research square·2023
Same author

Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer.

Nature communications·2023
Same author

Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.

Science translational medicine·2022
Same author

Author Correction: Radiation-activated secretory proteins of Scgb1a1<sup>+</sup> club cells increase the efficacy of immune checkpoint blockade in lung cancer.

Nature cancer·2022
Same author

Radiation-activated secretory proteins of <i>Scgb1a1</i><sup>+</sup> club cells increase the efficacy of immune checkpoint blockade in lung cancer.

Nature cancer·2021
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

Noncoding RNAs Regulating Cancer Signaling Network.

Jing Hu1, Geoffrey J Markowitz1, Xiaofan Wang2,3

  • 1Departments of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27710, USA.

Advances in Experimental Medicine and Biology
|July 5, 2016
PubMed
Summary
This summary is machine-generated.

Noncoding RNAs regulate cellular signaling in cancer, influencing key pathways and contributing to disease progression. Understanding these noncoding RNAs is crucial for cancer research and therapy.

Keywords:
CancerMicroRNANoncoding RNASignal transduction

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K

Related Experiment Videos

Last Updated: Mar 18, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Cellular signaling networks are critical in development and disease, particularly cancer.
  • Cancer cells deregulate signaling pathways, leading to uncontrolled proliferation, metastasis, and other hallmarks of cancer.
  • Noncoding RNAs significantly influence signal transduction in cancer, impacting tumorigenesis.

Purpose of the Study:

  • To provide an overview of the regulatory roles of noncoding RNAs in cancer cell signaling networks.
  • To summarize examples of noncoding RNAs acting as oncogenes or tumor suppressors in cancer.
  • To highlight the involvement of noncoding RNAs in key signaling pathways and signal crosstalk in cancer.

Main Methods:

  • Literature review and synthesis of existing research on noncoding RNAs and cancer signaling.
  • Analysis of studies detailing the function of specific noncoding RNAs in cancer pathways.
  • Compilation of examples illustrating oncogenic and tumor-suppressive roles of noncoding RNAs.

Main Results:

  • Noncoding RNAs are key regulators of signal transduction in cancer.
  • Examples of noncoding RNAs functioning as oncogenes or tumor suppressors in cancer are identified.
  • Noncoding RNAs participate in critical signaling pathways and signal crosstalk within cancer cells.

Conclusions:

  • Noncoding RNAs play a substantial role in regulating the cellular signaling network during cancer progression.
  • Targeting noncoding RNAs offers potential therapeutic strategies for cancer treatment.
  • Further research into noncoding RNA functions can elucidate complex cancer mechanisms.